Spirometry and Related Tests - PowerPoint PPT Presentation

1 / 115
About This Presentation
Title:

Spirometry and Related Tests

Description:

Spirometry and Related Tests RET 2414 Pulmonary Function Testing Module 2.0 Quiz Practice All of the following are true regarding the acceptability criteria of an FVC ... – PowerPoint PPT presentation

Number of Views:337
Avg rating:3.0/5.0
Slides: 116
Provided by: Phill151
Learn more at: https://faculty.mdc.edu
Category:

less

Transcript and Presenter's Notes

Title: Spirometry and Related Tests


1
Spirometry and Related Tests
  • RET 2414
  • Pulmonary Function Testing
  • Module 2.0

2
SPIROMETRY AND RELATED TESTS
  • Learning Objectives
  • Determine whether spirometry is acceptable and
    reproducible
  • Identify airway obstruction using forced vital
    capacity (FVC) and forced expiratory volume
    (FEV1)
  • Differentiate between obstruction and restriction
    as causes of reduced vital capacity

3
SPIROMETRY AND RELATED TESTS
  • Learning Objectives
  • Distinguish between large and small airway
    obstruction by evaluating flow-volume curves
  • Determine whether there is a significant response
    to bronchodilators
  • Select the appropriate FVC and FEV1 for reporting
    from series of spirometry maneuvers

4
Predicted Values
  • Laboratory Normal Ranges
  • Laboratory tests performed on a large number of
    normal population will show a range of results

5
Predicted Values
  • Laboratory Normal Ranges

6
Predicted Values
  • Laboratory Normal Ranges
  • Most clinical laboratories consider two standard
    deviations from the mean as the normal range
    since it includes 95 of the normal population.

7
PFT Reports
  • When performing PFTs three values are reported
  • Actual what the patient performed
  • Predicted what the patient should have
    performed based on Age, Height, Sex, Weight, and
    Ethnicity
  • Predicted a comparison of the actual value to
    the predicted value

8
PFT Reports
  • Example
  • Actual Predicted Predicted
  • VC 4.0 5.0 80

9
SPIROMETRY
  • Vital Capacity
  • The vital capacity (VC) is the volume of gas
    measured from a slow, complete expiration after a
    maximal inspiration, without a forced effort.

10
SPIROMETRY
  • Vital Capacity

11
SPIROMETRY
  • Vital Capacity
  • Valid VC measurements important
  • IC and ERV used to calculate
  • RV and TLC
  • Example
  • RV FRC - ERV
  • TLC IC FRC

12
SPIROMETRY
  • VC Criteria for Acceptability
  • End-expiratory volume varies by less than 100 ml
    for three preceding breaths
  • Volume plateau observed at maximal inspiration
    and expiration

13
SPIROMETRY
  • VC Criteria for Acceptability
  • Three acceptable VC maneuvers should be obtained
    volume within 150 ml.
  • VC should be within 150 ml of FVC value

14
SPIROMETRY
  • VC Selection Criteria
  • The largest value from at least 3 acceptable
    maneuvers should be reported

15
SPIROMETRY
  • VC Significance/Pathophysiology
  • Decreased VC
  • Loss of distensible lung tissue
  • Lung CA
  • Pulmonary edema
  • Pneumonia
  • Pulmonary vascular congestion
  • Surgical removal of lung tissue
  • Tissue loss
  • Space-occupying lesions
  • Changes in lung tissue

16
SPIROMETRY
  • VC Significance/Pathophysiology
  • Decreased VC
  • Obstructive lung disease
  • Respiratory depression or neuromuscular disease
  • Pleural effusion
  • Pneumothorax
  • Hiatal hernia
  • Enlarged heart

17
SPIROMETRY
  • VC Significance/Pathophysiology
  • Decreased VC
  • Limited movement of diaphragm
  • Pregnancy
  • Abdominal fluids
  • Tumors
  • Limitation of chest wall movement
  • Scleraderma
  • Kyphoscoliosis
  • Pain

18
SPIROMETRY
  • VC Significance/Pathophysiology
  • If the VC is less than 80 of predicted FVC can
    reveal if caused by obstruction

19
SPIROMETRY
  • VC Significance/Pathophysiology
  • If the VC is less than 80 of predicted Lung
    volume testing can reveal if caused by restriction

20
SPIROMETRY
  • Forced Vital Capacity (FVC)
  • The maximum volume of gas that can be expired
    when the patient exhales as forcefully and
    rapidly as possible after maximal inspiration
    (sitting or standing)

21
SPIROMETRY
  • FVC (should be within 150 ml of VC)

22
SPIROMETRY
  • FVC Criteria for Acceptability
  • Maximal effort no cough or glottic closure
    during the first second no leaks or obstruction
    of the mouthpiece.
  • Good start-of-test back extrapolated volume lt5
    of FVC or 150 ml, whichever is greater

23
SPIROMETRY
  • FVC Criteria for Acceptability
  • Tracing shows 6 seconds of exhalation or an
    obvious plateau (lt0.025L for 1s) no early
    termination or cutoff or subject cannot or
    should not continue to exhale

24
SPIROMETRY
  • FVC Criteria for Acceptability
  • Three acceptable spirograms obtained two largest
    FVC values within 150 ml two largest FEV1 values
    within 150 ml

25
SPIROMETRY
  • FVC Selection Criteria
  • The largest FVC and largest FEV1 (BTPS) should
    be reported, even if they do not come from the
    same curve

26
SPIROMETRY
  • FVC When to call it quits !!!
  • If reproducible values cannot be obtained after
    eight attempts, testing may be discontinued

27
SPIROMETRY
  • FVC Significance and Pathophysiology
  • FVC equals VC in healthy individuals
  • FVC is often lower in patients with obstructive
    disease

28
SPIROMETRY
  • FVC Significance and Pathophysiology
  • FVC can be reduced by
  • Mucus plugging
  • Bronchiolar narrowing
  • Chronic or acute asthma
  • Bronchiectasis
  • Cystic fibrosis
  • Trachea or mainstem bronchi obstruction

29
SPIROMETRY
  • FVC Significance and Pathophysiology
  • Healthy adults can exhale their FVC within 4 6
    seconds
  • Patients with severe obstruction (e.g.,
    emphysema) may require 20 seconds, however,
    exhalation times gt15 seconds will rarely change
    clinical decisions

30
SPIROMETRY
  • FVC Significance and Pathophysiology
  • FVC is also decreased in restrictive lung disease
  • Pulmonary fibrosis
  • dusts/toxins/drugs/radiation
  • Congestion of pulmonary blood flow
  • pneumonia/pulmonary hypertension/PE
  • Space occupying lesions
  • tumors/pleural effusion

31
SPIROMETRY
  • FVC Significance and Pathophysiology
  • FVC is also decreased in restrictive lung disease
  • Neuromuscular disorders, e.g,
  • myasthenia gravis, Guillain-Barre
  • Chest deformities, e.g,
  • scoliosis/kyphoscoliosis
  • Obesity or pregnancy

32
SPIROMETRY
  • Forced Expiratory Volume (FEV1)
  • The volume expired over the first second of an
    FVC maneuver

33
SPIROMETRY
  • Forced Expiratory Volume (FEV1)
  • May be reduced in obstructive or restrictive
    patterns, or poor patient effort

34
SPIROMETRY
  • Forced Expiratory Volume (FEV1)
  • In obstructive disease, FEV1 may be decreased
    because of
  • Airway narrowing during forced expiration
  • emphysema
  • Mucus secretions
  • Bronchospasm
  • Inflammation (asthma/bronchitis)
  • Large airway obstruction
  • tumors/foreign bodies

35
SPIROMETRY
  • Forced Expiratory Volume (FEV1)
  • The ability to work or function in daily life is
    related to the FEV1 and FVC
  • Patients with markedly reduced FEV1 values are
    more likely to die from COPD or lung cancer

36
SPIROMETRY
  • Forced Expiratory Volume (FEV1)
  • FEV1 may be reduced in restrictive lung processes
  • Fibrosis
  • Edema
  • Space-occupying lesions
  • Neuromuscular diseases
  • Obesity
  • Chest wall deformity

37
SPIROMETRY
  • Forced Expiratory Volume (FEV1)
  • FEV1 is the most widely used spirometric
    parameter, particularly for assessment of airway
    obstruction

38
SPIROMETRY
  • Forced Expiratory Volume (FEV1)
  • FEV1 is used in conjunction with FVC for
  • Simple screening
  • Response to bronchodilator therapy
  • Response to bronchoprovocation
  • Detection of exercise-induced bronchospasm

39
SPIROMETRY
  • Forced Expiratory Volume Ratio (FEVT)
  • FEVT FEVT/FVC x 100
  • Useful in distinguishing between obstructive and
    restrictive causes of reduced FEV1 values

40
SPIROMETRY
  • Forced Expiratory Volume Ratio (FEVT)
  • Normal FEVT Ratios for Health Adults
  • FEV 0.5 50-60
  • FEV 1 75-85
  • FEV 2 90-95
  • FEV 3 95-98
  • FEV 6 98-100
  • Patients with obstructive disease have reduced
    FEVT for each interval

41
SPIROMETRY
  • Forced Expiratory Volume Ratio (FEVT)
  • A decrease FEV1/FVC ratio is the hallmark of
    obstructive disease
  • FEV1/FVC lt75

42
SPIROMETRY
  • Forced Expiratory Volume Ratio (FEVT)
  • Patients with restrictive disease often have
    normal or increased FEVT values
  • FEV1 and FVC are usually reduced in equal
    proportions
  • The presence of a restrictive disorder may by
    suggested by a reduced FVC and a normal or
    increased FEV1/FVC ration

43
SPIROMETRY
  • Forced Expiratory Flow 25 - 75
  • (maximum mid-expiratory flow)
  • FEF 25-75 is measured from a segment of the FVC
    that includes flow from medium and small airways
  • Normal values 4 5 L/sec

44
SPIROMETRY
  • Forced Expiratory Flow 25 - 75
  • In the presence of a borderline value for
    FEV1/FVC, a low FEF 25-75 may help confirm
    airway obstruction

45
SPIROMETRY
  • Flow Volume Curve
  • AKA FlowVolume Loop (FVL)
  • The maximum expiratory flow-volume (MEFV) curve
    shows flow as the patient exhales from maximal
    inspiration (TLC) to maximal expiration (RV)
  • FVC followed by FIVC

46
SPIROMETRY
  • FVL
  • X axis Volume
  • Y axis Flow
  • PEF (Peak Expiratory Flow)
  • PIF (Peak Inspiratory Flow)
  • .
  • Vmax 75 or FEF 25
  • FVC Remaining or Percentage FVC exhaled
  • .
  • Vmax 50 or FEF 50
  • .
  • Vmax 25 or FEF 75

FEF 25 or Vmax 75
FEF 75 or Vmax 25
47
SPIROMETRY
  • FVL
  • FEVT and FEF can be read from the timing marks
    (ticks) on the FVL

48
SPIROMETRY
  • FVL
  • Significant decreases in flow or volume are
    easily detected from a single graphic display

49
SPIROMETRY
  • FVL Severe Obstruction

50
SPIROMETRY
  • FVL Bronchodilation

51
SPIROMETRY
  • Peak Expiratory Flow (PEF)
  • The maximum flow obtained during a FVC maneuver
  • Measured from a FVL
  • In laboratory, must perform a minimum of 3 PEF
    maneuvers
  • Largest 2 of 3 must be within 0.67 L/S (40 L/min)
  • Primarily measures large airway function
  • Many portable devices available

52
SPIROMETRY
  • Peak Expiratory Flow (PEF)
  • When used to monitor asthmatics
  • Establish best PEF over a 2-3 week period
  • Should be measured twice daily (morning and
    evening)
  • Daily measurements are compared to personal best

53
SPIROMETRY
  • Peak Expiratory Flow (PEF)
  • The National Asthma Education Program suggests a
    zone system
  • Green 80-100 of personal best
  • Routine treatment can be continued consider
    reducing medications
  • Yellow 50-80 of personal best
  • Acute exacerbation may be present
  • Temporary increase in medication may be needed
  • Maintenance therapy may need increases
  • Red Less than 50 of personal best
  • Bronchodilators should be taken immediately
    begin oral steroids clinician should be notified
    if PEF fails to return to yellow or green within
    2 4 hours

54
SPIROMETRY
  • Peak Expiratory Flow (PEF)
  • PEF is a recognized means of
  • monitoring asthma
  • Provides serial measurements
  • of PEF as a guide to treatment
  • ATS Recommended Ranges
  • 60-400 L/min (children)
  • 100-850 L/min (adults)

55
SPIROMETRY
  • Maximum Voluntary Ventilation (MVV)
  • The volume of air exhaled in a specific interval
    during rapid, forced breathing

56
SPIROMETRY
  • MVV
  • Rapid, deep breathing
  • VT 50 of VC
  • For 12-15 seconds

57
SPIROMETRY
  • MVV
  • Tests overall function of respiratory system
  • Airway resistance
  • Respiratory muscles
  • Compliance of lungs/chest wall
  • Ventilatory control mechanisms

58
SPIROMETRY
  • MVV
  • At least 2 acceptable maneuvers should be
    performed
  • Two largest should be within 10 of each other
  • Volumes extrapolated out to 60 seconds and
    corrected to BTPS
  • MVV is approximately equal to 35 time the FEV1

59
SPIROMETRY
  • MVV
  • Selection Criteria
  • The highest MVV (L/min, BTPS) and MVV rate
    (breaths / min) should be reported

60
SPIROMETRY
  • MVV
  • Decreased in
  • Patients with moderate to severe obstructive lung
    disease
  • Patients who are weak or have decreased endurance
  • Patients with neurological deficits

61
SPIROMETRY
  • MVV
  • Decreased in
  • Patients with paralysis or nerve damage
  • A markedly reduced MVV correlates with
    postoperative risk for patients having abdominal
    or thoracic surgery

62
SPIROMETRY
  • Before/After Bronchodilator
  • Spirometry is performed before and after
    bronchodilator administration to determine the
    reversibility of airway obstruction

63
SPIROMETRY
  • Before/After Bronchodilator
  • An FEV1 less than predicted is a good indication
    for bronchodilator study
  • In most patients, an FEV1 less than 70
    indicates obstruction

64
SPIROMETRY
  • Before/After Bronchodilator
  • Any pulmonary function parameter may be measured
    before and after bronchodilator therapy
  • FEV1 and specific airway conductance (SGaw) are
    usually evaluated

65
SPIROMETRY
  • Before/After Bronchodilator
  • Lung volumes should be recorded before
    bronchodilator administration
  • Lung volumes and DLco may also respond to
    bronchodilator therapy

66
SPIROMETRY
  • Before/After Bronchodilator
  • Routine bronchodilator therapy should be withheld
    prior to spirometry
  • Ruppel 9th edition, pg. 66 Table 2-2
  • Short-acting ß-agonists 4 hours
  • Short-acting anticholinergic 4 hours
  • Long-acting ß-agonists 12 hours
  • Long-acting anticholinergic 24 hours
  • Methylxanthines (theophyllines) 12 hours
  • Slow release methylxanthines 24 hours
  • Cromolyn sodium 8-12 hours
  • Leukotriene modifiers 24 hours
  • Inhaled steroids Maintain dosage

67
SPIROMETRY
  • Before/After Bronchodilator
  • Minimum of 10 minutes, up to 15 minutes, between
    administration and repeat testing is recommended
    (30 minutes for short-acting anticholinergic
    agents)
  • FEV1, FVC, FEF25-75, PEF, SGaw are commonly
    made before and after bronchodilator
    administration

68
SPIROMETRY
  • Before/After Bronchodilator
  • Percentage of change is calculated
  • Change Postdrug Predrug X 100
  • Predrug

69
SPIROMETRY
  • Before/After Bronchodilator
  • FEV1 is the most commonly used test for
    quantifying bronchodilator response
  • FEV1 should not be used to judge bronchodilation
    response
  • SGaw may show a marked increase after
    bronchodilator therapy

70
SPIROMETRY
  • Before/After Bronchodilator
  • Significance and Pathophysiology
  • Considered significant if
  • FEV1 or FVC increase 12 and 200 ml
  • SGaw increases 30 - 40

71
SPIROMETRY
  • Before/After Bronchodilator
  • Significance and Pathophysiology
  • Diseases involving the bronchial (and
    bronchiolar) smooth muscle usually improve most
    from before to after
  • Increase gt50 in FEV1 may occur in patients with
    asthma

72
SPIROMETRY
  • Before/After Bronchodilator
  • Significance and Pathophysiology
  • Patients with chronic obstructive diseases may
    show little improvement in flows
  • Inadequate drug deposition (poor inspiratory
    effort)
  • Patient may respond to different drug
  • Paradoxical response lt8 or 150 ml not
    significant

73
SPIROMETRY
  • Maximal Inspiratory Pressure (MIP)
  • The lowest pressure developed during a forceful
    inspiration against an occluded airway
  • Primarily measures inspiratory muscle strength

74
SPIROMETRY
  • MIP
  • Usually measured at maximal expiration (residual
    volume)
  • Can be measured at FRC
  • Recorded as a negative number in
  • cm H20 or mm Hg, e.g. (-60 cm H2O)

75
SPIROMETRY
  • MIP

76
SPIROMETRY
  • MIP
  • Significance and Pathophysiology
  • Healthy adults gt -60 cm H2O
  • Decreased in patients with
  • Neuromuscular disease
  • Diseases involving the diaphragm, intercostal, or
    accessory muscles
  • Hyperinflation (emphysema)

77
SPIROMETRY
  • MIP
  • Significance and Pathophysiology
  • Sometimes used to measure response to respiratory
    muscle training
  • Often used in the assessment of respiratory
    muscle function in patients who need ventilatory
    support

78
SPIROMETRY
  • Maximal Expiratory Pressure (MEP)
  • The highest pressure developed during a forceful
    exhalation against an occluded airway
  • Dependent upon function of the abdominal muscles,
    accessory muscles of expiration, and elastic
    recoil of lung and thorax

79
SPIROMETRY
  • MEP
  • Usually measured at maximal inspiration (total
    lung capacity)
  • Can be measured at FRC
  • Recorded as a positive number in cm H20 or mm Hg

80
SPIROMETRY
  • MIP and MEP

81
SPIROMETRY
  • MEP
  • Significance and Pathophysiology
  • Healthy adults gt80 to 100 cm H2O
  • Decreased in
  • Neuromuscular disorders
  • High cervical spine fractures
  • Damage to nerves controlling abdominal and
    accessory muscles of inspiration

82
SPIROMETRY
  • MEP
  • Significance and Pathophysiology
  • A low MEP is associated with inability to cough
  • May complicate chronic bronchitis, cystic
    fibrosis, and other diseases that result in
    excessive mucus production

83
SPIROMETRY
  • Airway Resistance (Raw)
  • The drive pressure required to create a flow of
    air through a subjects airway
  • Recorded in cm H2O/L/sec
  • When related to lung volume at the time of
    measurement it is known as specific airway
    resistance (SRaw)

84
SPIROMETRY
  • Raw
  • Measured in a plethysmograph as the patient
    breathes through a pneumo-tachometer

85
SPIROMETRY
  • Raw
  • Criteria of Acceptability
  • Mean of three or more acceptable efforts should
    be reported individual values should be within
    10 of mean

86
SPIROMETRY
  • Airway Resistance (Raw)
  • Normal Adult Values
  • Raw 0.6 2.4 cm H2O/L/sec
  • SRaw 0.190 0.667 cm H2O/L/sec/L

87
SPIROMETRY
  • Airway Resistance (Raw)
  • May be increased in
  • Bronchospasm
  • Inflammation
  • Mucus secretion
  • Airway collapse
  • Lesions obstructing the larger airways
  • Tumors, traumatic injuries, foreign bodies

88
SPIROMETRY
  • Raw
  • Significance and Pathology
  • Increased in acute asthmatic episodes
  • Increased in advanced emphysema because of airway
    narrowing and collapse
  • Other obstructive disease, e.g., bronchitis may
    cause increase in Raw proportionate to the degree
    of obstruction in medium and small airways

89
SPIROMETRY
  • Airway Conductance (Gaw)
  • A measure of flow that is generated from the
    available drive pressure
  • Recorded in L/sec/cm H2O
  • Gaw is the inverse of Raw
  • When related to lung volume at the time of
    measurement it is known as specific airway
    conductance (SGaw)

90
SPIROMETRY
  • Gaw
  • Measured in a plethysmograph as the patient
    breathes through a pneumo-tachometer

91
SPIROMETRY
  • Gaw
  • Criteria of Acceptability
  • Mean of three or more acceptable efforts should
    be reported individual values should be within
    10 of mean

92
SPIROMETRY
  • Airway Conductance (Gaw)
  • Normal Adult Values
  • Gaw 0.42 1.67 L/sec/cmH2O
  • SGaw 0.15 0.20 L/sec/cm H2O/L

93
SPIROMETRY
  • Airway Conductance (Gaw)
  • Significance and Pathology
  • SGaw Values lt0.15 0.20 L/sec/cm H2O/L are
    consistent with airway obstruction

94
Quiz Practice
  • Most clinical laboratories consider two standard
    deviations from the mean as the normal range when
    determining predicted values since it includes
    95 of the normal population.
  • False
  • Only for those individuals with lung disease
  • This applies only to cigarette smokers
  • True

95
Quiz Practice
  • Vital capacity is defined as which of the
    following?
  • The volume of gas measured from a slow, complete
    exhalation after a maximal inspiration, without a
    forced effort
  • The volume of gas measured from a rapid, complete
    exhalation after a rapid maximal inspiration
  • The volume of gas measured after 3 seconds of a
    slow, complete exhalation
  • The total volume of gas within the lungs after a
    maximal inhalation

96
Quiz Practice
  • Which of the following statements are true
    regarding the acceptability criteria for vital
    capacity measurement?
  • End-expiratory volume varies by less than 100 ml
    for three preceding breaths
  • Volume plateau observed at maximal inspiration
    and expiration
  • Three acceptable vital capacity maneuvers should
    be obtained volume within 150 ml
  • Vital capacity should be within 150 ml of forced
    vital capacity in healthy individuals
  • I, II, and IV
  • II, III, and IV
  • III and IV
  • I, II, III, IV

97
Quiz Practice
  • Which of the following best describes the Forced
    Vital Capacity (FVC) maneuver?
  • The volume of gas measured from a slow, complete
    exhalation after a maximal inspiration, without a
    forced effort
  • The volume of gas measured from a slow, complete
    exhalation after a rapid maximal inspiration
  • The volume of gas measured after 3 seconds of a
    rapid, complete exhalation
  • The maximum volume of gas that can be expired
    when the patient exhales as forcefully and
    rapidly as possible after maximal inspiration

98
Quiz Practice
  • All of the following are true regarding the
    acceptability criteria of an FVC maneuver EXCEPT?
  • Maximal effort, no cough or glottic closure
    during the first second no leaks of obstruction
    of the mouthpiece
  • Good start of test back extrapolated volume less
    than 5 of the FVC or 150 ml
  • Tracing shows a minimum of 3 seconds of
    exhalation
  • Three acceptable spirograms obtained two largest
    FVC values within 150 ml two largest FEV1 values
    within 150 ml

99
Quiz Practice
  • The FEV1 is the expired volume of the first
    second of the FVC maneuver.
  • True
  • False
  • Only when done slowly
  • Only when divided by the FVC

100
Quiz Practice
  • Which of following statements is true regarding
    FEV1?
  • FEV1 may be larger than the FVC
  • FEV1 is always 75 of FVC
  • May be reduced in obstructive and restrictive
    lung disease
  • Is only reduced in restrictive disease

101
Quiz Practice
  • The FEV1 is useful in distinguishing between
    obstructive and restrictive causes of reduced
    FEV1 values
  • True
  • False
  • Only helps to distinguish obstructive lung
    disease
  • Only helps to distinguish restrictive lung disease

102
Quiz Practice
  • Which statements are true regarding the FEV 1,
    also known as the FEV1/FVC?
  • A decreased FEV1/FVC is the hallmark of
    obstructive disease
  • Patients with restrictive lung disease often have
    normal or increased FEV1/FVC ratios
  • The presence of a restrictive disorder may be
    suggested by a reduced FVC and a normal or
    increased FEV1/FVC ratio
  • A normal FEV1/FVC ratio is between 75 - 85
  • I and II
  • I, II and III
  • II, III and IV
  • I, II, III and IV

103
Quiz Practice
  • What test is represented by the graph to the
    right?
  • Forced Vital Capacity
  • Flow-Volume Loop
  • Slow Vital Capacity
  • Total Lung Capacity Maneuver

104
Quiz Practice
  • What type of pulmonary disorder is represented
    by the graph below?
  • Obstructive lung disease
  • Restrictive lung disease
  • Upper airway obstruction
  • Normal lung function
  • (The dotted lines represent the predicted values)

105
Quiz Practice
  • Which is true regarding Peak Expiratory Flow
    (PEF)?
  • Primarily measures large airway function
  • Is a recognized means of monitoring asthma
  • Serial measurements of PEF are used a guide to
    treat asthma
  • When less than 50 of personal best, it is an
    indication that immediate treatment is required
  • I only
  • II and III
  • II, III, and IV
  • I, II, III, and IV

106
Quiz Practice
  • MVV is decreased in patients with which of the
    following disorders?
  • Moderate to severe obstructive lung disease
  • Weak or with decrease endurance
  • Neurological defects
  • Paralysis or nerve damage
  • I and IV
  • II and III
  • III and IV
  • I, II, III, and IV

107
Quiz Practice
  • Spirometry before and after bronchodilator
    therapy is used to determine which of the
    following?
  • Reversibility of airway obstruction
  • The severity of restrictive disorders
  • The rate at which CO diffuses through the lung
    into the blood
  • If the patient has exercised induced asthma

108
Quiz Practice
  • What is the minimum amount of time between
    administration of bronchodilator therapy and
    repeat pulmonary function testing?
  • 5 minutes
  • 10 minutes
  • 30 minutes
  • 60 minute

109
Quiz Practice
  • Bronchodilation is considered significant when
    which of the following occurs?
  • FEV1/FVC increases by 12
  • SGaw increases by 12
  • FVC and/or FEV1 increases by 12 and 150 ml
  • DLco increases by 12

110
Quiz Practice
  • Which of the following is true regarding Maximal
    Inspiratory Pressure (MIP)?
  • Primarily measures inspiratory muscle strength
  • Measures airway resistance during inspiration
  • Is decreased in patients with neurological
    disease
  • Often used in the assessment of respiratory
    muscle function in patients who need ventilatory
    support
  • I, II, and III
  • I, III, and IV
  • II and III
  • II, III, and IV

111
Quiz Practice
  • Airway resistance (Raw) is the drive pressure
    required to create a flow of air through a
    subjects airway.
  • True
  • False
  • Only in patients with COPD
  • Only in patients with restrictive disorders

112
Quiz Practice
  • Airway resistance may be increased in which of
    the following patients?
  • Purely restrictive lung disorders
  • Acute asthmatic episodes
  • Mucus secretion
  • Lung compliance changes
  • I only
  • I and IV
  • II and III
  • I, II, III, and IV

113
Quiz Practice
  • Airway Conductance (Gaw) is a measure of flow
    that is generated from the available drive
    pressure.
  • True
  • False
  • Only in patients with COPD
  • Only in patients with restrictive disorders

114
Quiz Practice
  • A patients pulmonary function tests reveal the
    following
  • Actual Predicted Predicted
  • FVC 4.01 L 4.97 L 81
  • FEV1 2.58 L 3.67 L 56
  • FEV1 51 gt75 _
  • Select the correct interpretation
  • Restrictive pattern
  • Obstructive pattern
  • Inconclusive
  • Normal

115
Quiz Practice
  • A patients pulmonary function tests reveal the
    following
  • Actual Predicted Predicted
  • FVC 3.75 L 4.97 L 75
  • FEV1 2.80 L 3.67 L 76
  • FEV1 75 gt/75 _
  • Select the correct interpretation
  • Restrictive pattern
  • Obstructive pattern
  • Inconclusive
  • Normal
Write a Comment
User Comments (0)
About PowerShow.com